Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China · Delayed Price · Currency is CNY 5.94
+0.17 (2.95%)
Nov 6, 2026, 9:25 AM CST
SHE:300942 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 280.69 | 263.23 | 224.25 | 254.11 | 686.9 | 597.54 |
Revenue Growth | 11.46% | 17.38% | -11.75% | -63.01% | 14.95% | 131.20% |
Gross Profit Gross Profit Growth | 167.2 | 166.04 | 156.1 | 96.19 | 341.89 | 426.16 |
Operating Income Operating Income Growth | 4.75 | 15.5 | 16.45 | -114.47 | 72.76 | 248.1 |
Net Income Net Income Growth | -31.68 | 13.74 | 17.12 | -184.91 | 82.97 | 236.51 |
Earnings Per Share EPS Growth | -0.07 | 0.03 | 0.04 | -0.46 | 0.21 | 0.60 |
EPS Growth | - | -25.00% | - | - | -65.00% | 233.33% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Food Rapid Testing Business Food Rapid Testing Business Growth | 237.43 | 208.51 | 198.03 | 184.94 | 182.53 |
Animal Disease Detection Animal Disease Detection Growth | 14.46 | 13.74 | 8.39 | 2.51 | - |
Park Operation Services Park Operation Services Growth | 11.34 | - | - | - | - |
in Vitro Diagnostic Business in Vitro Diagnostic Business Growth | - | 2 | 47.69 | 499.44 | 415.01 |
Total Total Growth | 263.23 | 224.25 | 254.11 | 686.9 | 597.54 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 544.11 | 628.13 | 596.31 | 601.78 | 429.36 | 682.42 |
Total Debt Total Debt Growth | 453.39 | 447.55 | 467.98 | 365.87 | 119.34 | 41.12 |
Net Cash (Debt) Net Cash Growth | 90.72 | 180.59 | 128.33 | 235.91 | 310.02 | 641.31 |
Net Cash Growth | -39.67% | 40.72% | -45.60% | -23.91% | -51.66% | 69.17% |
Net Cash Per Share Net Cash Per Share Growth | 0.20 | 0.39 | 0.30 | 0.59 | 0.78 | 1.63 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 39.22 | 66.87 | 34.26 | -37.25 | 152.55 | 255.42 |
Capital Expenditures CapEx Growth | -54.36 | -45.9 | -174.1 | -128.64 | -176.85 | -79.51 |
Free Cash Flow Free Cash Flow Growth | -15.13 | 20.97 | -139.85 | -165.89 | -24.29 | 175.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 59.57% | 63.08% | 69.61% | 37.85% | 49.77% | 71.32% |
Operating Margin | 1.69% | 5.89% | 7.34% | -45.05% | 10.59% | 41.52% |
Pretax Margin | -13.41% | 5.05% | 8.78% | -69.97% | 13.81% | 44.86% |
Profit Margin | -11.29% | 5.22% | 7.63% | -72.77% | 12.08% | 39.58% |
FCF Margin | -5.39% | 7.97% | -62.36% | -65.29% | -3.54% | 29.44% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.025 | 0.025 | 0.017 | - | 0.021 | 0.249 |
Dividend Per Share Growth | 41.51% | 41.51% | - | - | -91.49% | 453.33% |
Dividend Yield | 0.42% | 0.26% | 0.20% | - | 0.12% | 0.86% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | 277.35 | 200.71 | - | 82.81 | 48.92 |
P/FCF Ratio | - | 181.75 | - | - | - | 65.76 |
PS Ratio | 8.57 | 14.48 | 15.32 | 18.44 | 10.00 | 19.36 |